TY  - JOUR

T1  - Rifaximin, Omeprazole and Levofloxacin for the Treatment of Helicobacter pylori in the Treatment-Naive Population

JO  - American Journal of Gastroenterology

UR  - https://doi.org/10.14309/00000434-200609001-00144

PY  - 2006/09/01

AU  - Basu PP

AU  - Palumbo FM

AU  - Maltby M

AU  - Hussain S

AU  - Somnay K

AU  - Mendis RE

ED  - 

DO  - DOI: 10.14309/00000434-200609001-00144

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 101

SP  - S90

EP  - S91

Y2  - 2025/12/05

ER  -